
Inventiva announces the appointment of Dr. Michael Cooreman as Chief Medical Officer
Daix (France), November 5, 2020 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), …